DZ2947A1 - Inhalateur à compteur de dose sous pression. - Google Patents

Inhalateur à compteur de dose sous pression.

Info

Publication number
DZ2947A1
DZ2947A1 DZ990247A DZ990247A DZ2947A1 DZ 2947 A1 DZ2947 A1 DZ 2947A1 DZ 990247 A DZ990247 A DZ 990247A DZ 990247 A DZ990247 A DZ 990247A DZ 2947 A1 DZ2947 A1 DZ 2947A1
Authority
DZ
Algeria
Prior art keywords
metered dose
dose inhaler
pressure metered
pressure
inhaler
Prior art date
Application number
DZ990247A
Other languages
English (en)
French (fr)
Inventor
David Lewis
Brian Meakin
Gaetano Brambilla
David Ganderton
Paola Ventura
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2947(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI982559 external-priority patent/IT1303789B1/it
Priority claimed from IT1999MI001712 external-priority patent/IT1313582B1/it
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DZ2947A1 publication Critical patent/DZ2947A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Measurement Of Radiation (AREA)
DZ990247A 1998-11-25 1999-11-22 Inhalateur à compteur de dose sous pression. DZ2947A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI982559 IT1303789B1 (it) 1998-11-25 1998-11-25 "inalatori dosati pressurizzati"
IT1999MI001712 IT1313582B1 (it) 1999-07-30 1999-07-30 Inalatori dosati pressurizzati.

Publications (1)

Publication Number Publication Date
DZ2947A1 true DZ2947A1 (fr) 2004-03-15

Family

ID=26331622

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990247A DZ2947A1 (fr) 1998-11-25 1999-11-22 Inhalateur à compteur de dose sous pression.

Country Status (36)

Country Link
US (8) US7347199B1 (es)
EP (4) EP1674079A3 (es)
JP (1) JP2002530156A (es)
KR (1) KR100696746B1 (es)
CN (1) CN1200690C (es)
AR (1) AR021391A1 (es)
AT (2) ATE485812T1 (es)
AU (1) AU764696C (es)
BG (1) BG65596B1 (es)
BR (1) BR9916868B1 (es)
CA (2) CA2352484C (es)
CO (1) CO5170487A1 (es)
CY (1) CY1105356T1 (es)
CZ (1) CZ301305B6 (es)
DE (3) DE29923839U1 (es)
DK (1) DK1131051T3 (es)
DZ (1) DZ2947A1 (es)
EA (1) EA004132B1 (es)
EE (1) EE04259B1 (es)
EG (1) EG25278A (es)
ES (1) ES2255767T3 (es)
GE (1) GEP20033129B (es)
HK (1) HK1040063B (es)
HU (1) HU226735B1 (es)
IL (3) IL143294A0 (es)
MA (1) MA26764A1 (es)
NO (1) NO330194B1 (es)
NZ (2) NZ511926A (es)
PL (2) PL200658B1 (es)
SA (1) SA99200825B1 (es)
SI (1) SI1131051T1 (es)
SK (1) SK285246B6 (es)
TN (1) TNSN99220A1 (es)
TR (2) TR200704956T2 (es)
TW (1) TWI226247B (es)
WO (1) WO2000030608A1 (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6739333B1 (en) 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
AU2000250701B2 (en) * 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020085978A1 (en) * 2000-11-10 2002-07-04 Mina Buenafe Degradation-resistant glucocorticosteroid formulations
GB0106046D0 (en) * 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
SI1273292T1 (en) * 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
DK3494995T3 (da) * 2002-03-01 2020-03-23 Chiesi Farm Spa Superfin formoterolformulering
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
US20040126325A1 (en) * 2002-03-12 2004-07-01 David Lewis Medicinal aerosol solution formulation products with improved chemical stability
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
AU2003293528A1 (en) * 2003-02-04 2004-09-06 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
CN1761455A (zh) 2003-03-20 2006-04-19 贝林格尔·英格海姆药物公司 采用氢－氟－烷作为推进剂的计量剂量吸入器制剂
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
US20060225733A1 (en) 2003-06-24 2006-10-12 Cipla Limited Pharmaceutical dispensing aid
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP1684717A2 (en) * 2003-10-20 2006-08-02 Schering Corporation Pharmaceutical aerosol compositions
KR20070000476A (ko) * 2004-02-27 2007-01-02 키에시 파르마슈티시 엣스. 피. 에이. 압축화 계량된 도스흡입용 안정된 약제용액 제제
CN100457087C (zh) * 2004-02-27 2009-02-04 奇斯药制品公司 用于加压计量吸入器的稳定的药用溶液制剂
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
BRPI0512878A (pt) 2004-07-02 2008-04-15 Boehringer Ingelheim Int formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
SG159550A1 (en) 2005-02-25 2010-03-30 Chiesi Farma Spa Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
CA2603433A1 (en) * 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
JP5908884B2 (ja) 2010-03-15 2016-04-26 ヴァージニア コモンウェルス ユニヴァーシティＶｉｒｇｉｎｉａ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｕｎｉｖｅｒｓｉｔｙ 気道炎症及び粘液線毛輸送機能異常治療用のエアロゾル化したダプソン
NZ605920A (en) * 2010-07-16 2015-01-30 Cipla Ltd Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
CN102379846B (zh) * 2011-10-21 2014-07-02 江苏长风药业有限公司 以氢氟烷烃和聚乙二醇为辅料氟替卡松丙酸酯气雾剂制剂
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
CN103207032A (zh) * 2012-01-13 2013-07-17 热敏碟公司 低型面温度传感器探针
KR101313993B1 (ko) * 2012-07-24 2013-10-01 한국화학연구원 약물 흡입 장치
DE102013214601B3 (de) 2013-07-25 2014-05-22 Aptar Radolfzell Gmbh Gehäuse für eine Inhalationsvorrichtung und Inhalationsvorrichtung zur oralen Verabreichung eines pharmazeutischen Mediums
US10034866B2 (en) * 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US10610512B2 (en) * 2014-06-26 2020-04-07 Island Breeze Systems Ca, Llc MDI related products and methods of use
US10679342B2 (en) 2014-09-08 2020-06-09 Becton, Dickinson And Company Aerodynamically streamlined enclosure for input devices of a medication preparation system
CN106620976B (zh) * 2016-12-28 2020-01-07 四川普锐特医药科技有限责任公司 一种丙酸氟替卡松定量吸入气雾剂
US10231948B2 (en) 2017-02-27 2019-03-19 Jason Ty Nguyen Metered dose inhaler compositions, systems, and methods
EP3806939B1 (en) * 2018-06-13 2024-04-10 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US220718A (en) * 1879-10-21 Improvement in street-car warmers
US154013A (en) * 1874-08-11 Improvement in carriage-lamps
BE555319A (es) * 1956-03-21 1900-01-01
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
CA882187A (en) 1968-03-13 1971-09-28 Farbenfabriken Bayer Aktiengesellschaft Thermoplastic-elastic moulding compounds
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
EP0468022B1 (de) 1990-02-14 1994-12-28 systec POS-Technology GmbH Transportwagen mit münzschloss
IT1244441B (it) * 1990-09-13 1994-07-15 Chiesi Farma Spa Dispositivo per l'inalazione boccale di farmaci aerosol
KR930703251A (ko) 1990-12-19 1993-11-29 스튜어트 알. 슈터 에어로졸 제제
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69227189T2 (de) 1991-05-21 1999-02-25 Abbott Lab Aerosolinhalationsvorrichtung
BR9206422A (pt) * 1991-08-29 1995-10-17 Christoph Klein Aparelho médico para a inalação de aerossóis dosados
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
US5219882A (en) 1991-10-24 1993-06-15 Emil Bisaccia Treatment methods for lymes disease and associated debilitating conditions
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
AU675633B2 (en) 1991-12-18 1997-02-13 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
AU6048694A (en) 1992-12-09 1994-07-04 Paul D. Jager Stabilized medicinal aerosol solution formulations
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
WO1994014490A1 (de) 1992-12-23 1994-07-07 Bernhard Hugemann Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel
EP0689423B1 (en) 1993-03-17 1997-09-17 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
AU679511B2 (en) 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
CA2178473C (en) * 1993-12-20 2004-08-24 Tsi-Zong Tzou Flunisolide aerosol formulations
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
SK81197A3 (en) 1994-12-22 1997-11-05 Astra Ab Aerosol drug formulations, method for production thereof and its use
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5653961A (en) 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
CN1217654C (zh) * 1995-04-14 2005-09-07 史密丝克莱恩比彻姆公司 舒喘宁的计定剂量吸入器
ATE258813T1 (de) * 1995-04-14 2004-02-15 Smithkline Beecham Corp Vorrichtung zur dosierten inhalierung von beclomethason-diproprionat
CN1113675C (zh) 1995-04-14 2003-07-09 葛兰素惠尔康公司 丙酸福地卡松的计定剂量吸入器
ATE297773T1 (de) * 1995-04-14 2005-07-15 Smithkline Beecham Corp Dosierinhalator für salmeterol
US5637505A (en) * 1995-05-19 1997-06-10 Chiron Diagnostics Corporation Method to prepare dye-based reference material
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
JP2000514085A (ja) 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
IES80485B2 (en) * 1996-12-04 1998-08-12 Bioglan Ireland R & D Ltd Pharmaceutical compositions and devices for their administration
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
AUPO429396A0 (en) * 1996-12-20 1997-01-23 Solsearch Pty Ltd Solar energy collector system
JP2001511160A (ja) * 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
AU744057C (en) 1997-06-12 2003-04-10 Pac Holding S.A. Method for the disposal of waste products containing hydrocarbons and/or halogenated waste products
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
TR200003721T2 (tr) 1998-06-18 2001-06-21 Boehringer Ingelheim Pharmaceuticals, Inc. Spreyler için farmasötik formülasyonlar
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
DE59911149D1 (de) 1998-07-24 2004-12-30 Jago Res Ag Muttenz Medizinische aerosolformulierungen
NZ509489A (en) 1998-08-04 2002-10-25 Jago Res A Medicinal aerosol formulations comprising cromoglycic acid and/or nedocromil
DK1121112T3 (da) 1998-10-17 2002-09-16 Boehringer Ingelheim Pharma Lagringsdygtigt koncentrat af aktivt stof med formoterol
DE19847969A1 (de) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
US6086379A (en) * 1998-10-20 2000-07-11 Research Foundation Of State University Of New York System and method for training a swimmer
SK284889B6 (sk) 1998-11-13 2006-02-02 Jago Research Ag Použitie stearátu horečnatého v suchých práškových formuláciách na inhaláciu
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
PT1158958E (pt) 1999-03-05 2007-08-13 Chiesi Farma Spa ''composições farmacêuticas em pó, melhoradas, para inalação''
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
EP1248597B1 (en) 1999-12-24 2005-03-30 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2000250701B2 (en) * 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
SI1273292T1 (en) * 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
EP1340492A1 (en) 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
DK3494995T3 (da) 2002-03-01 2020-03-23 Chiesi Farm Spa Superfin formoterolformulering
US6808684B2 (en) 2002-04-05 2004-10-26 International Flavors & Fragrance Inc. Fragrance material
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
CA2352484A1 (en) 2000-06-02
EA200100468A1 (ru) 2001-12-24
DK1131051T3 (da) 2006-04-18
PL200658B1 (pl) 2009-01-30
CY1105356T1 (el) 2010-03-03
ATE314838T1 (de) 2006-02-15
US7740463B2 (en) 2010-06-22
PL348717A1 (en) 2002-06-03
TNSN99220A1 (fr) 2001-12-31
EP1523975A3 (en) 2005-08-31
US20110100361A1 (en) 2011-05-05
KR20010080543A (ko) 2001-08-22
CA2352484C (en) 2010-05-04
SK285246B6 (sk) 2006-09-07
HU226735B1 (en) 2009-08-28
EP1523975B1 (en) 2010-10-27
HK1040063B (zh) 2006-04-21
IL179491A0 (en) 2007-05-15
SA99200825B1 (ar) 2006-11-07
AR021391A1 (es) 2002-07-17
CN1328445A (zh) 2001-12-26
EP1674079A2 (en) 2006-06-28
GEP20033129B (en) 2003-12-25
NZ511926A (en) 2003-10-31
HK1040063A1 (en) 2002-05-24
EA004132B1 (ru) 2003-12-25
HUP0104411A2 (hu) 2002-03-28
CN1200690C (zh) 2005-05-11
NO20012516D0 (no) 2001-05-22
MA26764A1 (fr) 2004-12-20
IL143294A (en) 2007-05-15
EP1674079A3 (en) 2006-07-05
NO330194B1 (no) 2011-03-07
EG25278A (en) 2011-12-05
ES2255767T3 (es) 2006-07-01
NZ527190A (en) 2005-04-29
EE04259B1 (et) 2004-04-15
CA2698376A1 (en) 2000-06-02
EP1523975A2 (en) 2005-04-20
WO2000030608A1 (en) 2000-06-02
DE69929358D1 (de) 2006-03-30
SK7042001A3 (en) 2001-11-06
BG65596B1 (bg) 2009-02-27
CZ301305B6 (cs) 2010-01-06
AU1556300A (en) 2000-06-13
CO5170487A1 (es) 2002-06-27
EP1131051A1 (en) 2001-09-12
DE29923839U1 (de) 2001-03-01
BR9916868A (pt) 2001-11-06
DE69929358T2 (de) 2006-07-13
PL204572B1 (pl) 2010-01-29
KR100696746B1 (ko) 2007-03-19
ATE485812T1 (de) 2010-11-15
US20080115782A1 (en) 2008-05-22
CZ20011834A3 (cs) 2001-12-12
TWI226247B (en) 2005-01-11
US7223381B2 (en) 2007-05-29
AU764696B2 (en) 2003-08-28
SI1131051T1 (sl) 2006-04-30
US20080247965A1 (en) 2008-10-09
US20030066525A1 (en) 2003-04-10
TR200101441T2 (tr) 2001-08-21
HUP0104411A3 (en) 2002-12-28
AU764696C (en) 2004-06-24
US8142763B2 (en) 2012-03-27
EP1131051B1 (en) 2006-01-04
NO20012516L (no) 2001-07-23
EP1666029A1 (en) 2006-06-07
IL143294A0 (en) 2002-04-21
US7347199B1 (en) 2008-03-25
BR9916868B1 (pt) 2011-02-08
EE200100276A (et) 2002-12-16
US20030089369A1 (en) 2003-05-15
US20040096399A1 (en) 2004-05-20
JP2002530156A (ja) 2002-09-17
BG105532A (bg) 2001-12-29
US20050142071A1 (en) 2005-06-30
DE69942896D1 (de) 2010-12-09
TR200704956T2 (tr) 2008-01-21

Similar Documents

Publication Publication Date Title
DZ2947A1 (fr) Inhalateur à compteur de dose sous pression.
NO20011257L (no) Forbedret inhalator
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
EE04005B1 (et) Salmeterooli doseeriv inhalaator
ATE238776T1 (de) Geschmacksmaskierte pharmazeutische dosisform mit schneller freisetzung
ZA99283B (en) Inhaler for medication.
AU4417101A (en) Metered dose inhaler
AU2001256168A1 (en) Metered dose inhaler
AU4831801A (en) Metered dose inhaler
ZA989536B (en) Medical face mask.
AU4417001A (en) Metered dose inhaler
MA26677A1 (fr) Medicaments antiparkinsoniens.
GB0020978D0 (en) Metered dose inhaler
GB9816356D0 (en) Medicament inhalers
ES1037749Y (es) Respiratorio nasal.
SE9700946D0 (sv) Powder inhaler VIII
GB0004763D0 (en) Metered dose inhaler
GB0018653D0 (en) Metered dose inhaler
GB0004761D0 (en) Metered dose inhaler
GB0018624D0 (en) Metered dose inhaler
GB0018625D0 (en) Metered dose inhaler
GB0018652D0 (en) Metered dose inhaler
GB0018675D0 (en) Metered dose inhaler
GB0018684D0 (en) Metered dose inhaler
GB0018674D0 (en) Metered dose inhaler